4.7 Article

Transmission of mcr-1-Producing Multidrug-resistant Enterobacteriaceae in Public Transportation in Guangzhou, China

期刊

CLINICAL INFECTIOUS DISEASES
卷 67, 期 -, 页码 S217-S224

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciy661

关键词

mcr-1; Escherichia coli; Klebsiella pneumonia; public transportation

资金

  1. National Natural Science Foundation of China [81722030, 81830103, 81471988]
  2. Guangdong Natural Science Foundation [2017A030306012]
  3. Science and Technology Planning Project of Guangdong [2016A020219002]
  4. 111 Project [B13037, B12003]

向作者/读者索取更多资源

Objectives. mcr-1-mediated colistin resistance in bacteria is concerning, as colistin is used in treating multidrug-resistant bacterial infections. And mcr-1-producing bacteria have been identified in multiple sources. Up to 248 million people use public transportation daily in China, however; public transportation hasn't been studied as a potential source of community-based transmission of mcr-1. Herein we investigated mcr-1-producing isolates from public transportation and explored the genomic characteristics of them. Methods. Surface samples were collected from public transportation in Guangzhou, China, from October 2016 to April 2017. Polymerase chain reaction was performed to detect mcr-1 gene, plasmid replicon type and phylogenetic group. Minimum inhibitory concentrations (MICs) were determined by microdilution method. S1-nuclease digestion and pulsed-field gel electrophoresis (S1-PFGE) and Southern blotting were performed with mcr-1-harboring plasmids. Whole-genome sequencing was performed with mcr-1-producing isolates. Results. Of the 737 samples with bacterial growth, 26 isolates were positive for mcr-1, including 23 Escherichia coli and 3 Klebsiella pneumoniae isolates. The E. coli isolates belonged to phylogroups A and B1. Most mcr-1-producing isolates were resistant to ampicillin (25), cefotaxime (21), fosfomycin (16), and gentamicin (15). S1-PFGE, Southern blotting and replicon typing showed that mcr-1 was mainly located on similar to 33.3 kb to similar to 220 kb IncX4, IncI2 and IncHI2 plasmids in E. coli, while located on similar to 33.3 kb untyped plasmid in K. pneumoniae. Several sequence types (ST), including ST2253, ST101, ST10 complex and ST37, were revealed. Between 53 and 66 (mean = 61.8) resistance genes were identified among mcr-1-producing isolates. Conclusions. Public transportation may serve as a source of mcr-1-producing bacteria.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biotechnology & Applied Microbiology

Comparative genomic analyses of Polymyxin-resistant Enterobacteriaceae strains from China

Zhien He, Yongqiang Yang, Wei Li, Xiaoling Ma, Changfeng Zhang, Jingxiang Zhang, Baolin Sun, Tao Ding, Guo-Bao Tian

Summary: This study provides important information on Enterobacteriaceae bacteria carrying mcr-like genes and serves as a reference for the study of mcr-1 transmission in China and globally.

BMC GENOMICS (2022)

Article Ecology

Expression level is a major modifier of the fitness landscape of a protein coding gene

Zhuoxing Wu, Xiujuan Cai, Xin Zhang, Yao Liu, Guo-bao Tian, Jian-Rong Yang, Xiaoshu Chen

Summary: This study found that the phenotypic effects of genetic mutations are related to gene expression levels, with at least 42% of single-nucleotide mutations showing fitness effects dependent on gene expression levels and influenced by stochastic molecular errors.

NATURE ECOLOGY & EVOLUTION (2022)

Review Urology & Nephrology

Guideline of guidelines: management of recurrent urinary tract infections in women

Michael Kwok, Stephen McGeorge, Johanna Mayer-Coverdale, Bianca Graves, David L. Paterson, Patrick N. A. Harris, Rachel Esler, Caroline Dowling, Sumudu Britton, Matthew J. Roberts

Summary: This study compares recurrent urinary tract infection guidelines from major urological and non-urological organizations internationally. The results show that there is consistency in the definition and evaluation of rUTIs, as well as antibiotic prophylaxis strategies. However, there are variations in symptomatic treatment and antibiotic-sparing preventative strategies.

BJU INTERNATIONAL (2022)

Article Microbiology

Morganella morganii, an Emerging Cause of Bloodstream Infections

Kevin B. Laupland, David L. Paterson, Felicity Edwards, Adam G. Stewart, Patrick N. A. Harris

Summary: The incidence of Morganella morganii bloodstream infections is increasing in Queensland, Australia, with elderly male subjects and individuals with comorbidities at the highest risk. Although antibiotic resistance is not a major contributor to the current burden, ongoing surveillance is necessary.

MICROBIOLOGY SPECTRUM (2022)

Article Microbiology

Evaluating Mono- and Combination Therapy of Meropenem and Amikacin against Pseudomonas aeruginosa Bacteremia in the Hollow-Fiber Infection Model

Minyon L. Avent, Kate L. McCarthy, Fekade B. Sime, Saiyuri Naicker, Aaron J. Heffernan, Steven C. Wallis, David L. Paterson, Jason A. Roberts

Summary: The role of combination antibiotic therapy for Pseudomonas aeruginosa infections is still debated. This study found that combination therapy with amikacin and meropenem increased bacterial killing for susceptible isolates, while only the combination therapy demonstrated killing for meropenem-resistant isolates.

MICROBIOLOGY SPECTRUM (2022)

Article Microbiology

The Small RNA AmiL Regulates Quorum Sensing-Mediated Virulence in Pseudomonas aeruginosa PAO1

Jieying Pu, Shebin Zhang, Xi He, Jianming Zeng, Cong Shen, Yanfen Luo, Honglin Li, Yifei Long, Jianping Liu, Qian Xiao, Yang Lu, Bin Huang, Cha Chen

Summary: A novel QS regulatory sRNA AmiL has been identified in P. aeruginosa, which influences diverse QS-mediated virulence factors and regulates QS gene expression and C4-HSL production.

MICROBIOLOGY SPECTRUM (2022)

Article Infectious Diseases

Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial

David L. Paterson, Matteo Bassetti, Mary Motyl, Matthew G. Johnson, Mariana Castanheira, Erin H. Jensen, Jennifer A. Huntington, Brian Yu, Dominik J. Wolf, Christopher J. Bruno

Summary: This study confirms the efficacy of ceftolozane/tazobactam in treating HABP/VABP involving ESBL-positive and/or AmpC-producing pathogens.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

Article Infectious Diseases

Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility

Abdulrahman K. S. Ayfan, Joanne Macdonald, Adam D. Irwin, Hosam M. Zowawi, Brian M. Forde, David L. Paterson, Monica M. Lahra, David M. Whiley

Summary: This study developed instrument-free point-of-care methods using RPA technology and a simple lateral flow detection system to detect Neisseria gonorrhoeae and susceptibility to ciprofloxacin. The results showed that the developed assays were specific to N. gonorrhoeae and could effectively detect infections and antibiotic susceptibility.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

Letter Infectious Diseases

Antimicrobial susceptibility testing in clinical Mycobacterium tuberculosis isolates

Jiachen Li, Siyuan Feng, Yuhui Chen, Meiling Yu, Wenjing Wei, Guo-Bao Tian

LANCET MICROBE (2023)

Article Infectious Diseases

Duration of antibiotic treatment and timing of oral switching for bloodstream infections: a survey on the practices of infectious diseases and intensive care physicians

Burcu Isler, Abdullah Tarik Aslan, Burhan Sami Benli, David L. Paterson, Nick Daneman, Robert Fowler, Murat Akova

Summary: This study investigated the current practice of antibiotic treatment duration and timing of IV to oral switching for common bacteraemic conditions among Turkish infectious disease and ICU physicians. The results showed that the most commonly recommended duration of antibiotic treatment for bacteraemia was 14 days, followed by 10 and 7 days. Most physicians recommended switching to oral antibiotics after 7 days of IV treatment. Prolonged treatment durations may be due to a presumption that resistant bacterial infections require longer therapy.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)

Article Microbiology

Using Genomics To Investigate an Outbreak of Vancomycin-Resistant Enterococcus faecium ST78 at a Large Tertiary Hospital in Queensland

Budi Permana, Patrick N. A. Harris, Naomi Runnegar, Margaret Lindsay, Belinda C. Henderson, E. G. Playford, David L. Paterson, Scott A. Beatson, Brian M. Forde

Summary: An outbreak of vanB-type VREfm ST78 occurred in a large tertiary Australian hospital. Whole-genome sequencing revealed a complex transmission route involving unknown environmental reservoirs. This genomic analysis provided detailed information on the local epidemiology of the outbreak strain and facilitated better targeted control measures for VREfm.

MICROBIOLOGY SPECTRUM (2023)

Article Engineering, Biomedical

Arginine-Enhanced Antimicrobial Activity of Nanozymes against Gram-Negative Bacteria

Zihan Zhao, Shu'an Wen, Ningning Song, Lixiang Wang, Yuan Zhou, Xue Deng, Changbu Wu, Guili Zhang, Jun Chen, Guo-Bao Tian, Minmin Liang, Lan-Lan Zhong

Summary: This study demonstrates that combining antimicrobial nanozymes with L-arginine can effectively treat difficult-to-treat Gram-negative pathogen infections. The combination treatment enhances bacterial membrane permeability and promotes ROS production, leading to the killing of pathogens.

ADVANCED HEALTHCARE MATERIALS (2023)

Article Microbiology

Molecular epidemiology and genomic dynamics of Pseudomonas aeruginosa isolates causing relapse infections

Cong Shen, Jinxiang Zeng, Dexiang Zheng, Yinglun Xiao, Jieying Pu, Li Luo, Hongyun Zhou, Yimei Cai, Liling Zhang, Meina Wu, Xuan Zhang, Guangyuan Deng, Song Li, Qiwei Li, Jianming Zeng, Zhaohui Sun, Bin Huang, Cha Chen

Summary: Pseudomonas aeruginosa (P. aeruginosa) is a leading cause of chronic infections, and relapse infections are more common in carbapenem-resistant strains. This study identified relapse infections in a tertiary hospital in China and found that they were not caused by specific lineages. Genomic changes, including antimicrobial resistance and gene mutations, were observed during relapse episodes. A specific mutation in the fptA gene could be a potential target for the diagnosis and treatment of relapse P. aeruginosa infection.

MICROBIOLOGY SPECTRUM (2023)

Article Microbiology

Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study

Xin Wen, Cong Shen, Jinyu Xia, Lan-Lan Zhong, Zhongwen Wu, Mohamed Abd El-Gawad El-Sayed Ahmed, Nana Long, Furong Ma, Guili Zhang, Wenwei Wu, Jianlve Luo, Yong Xia, Min Dai, Liyan Zhang, Kang Liao, Siyuan Feng, Cha Chen, Yishen Chen, Wenji Luo, Guo-Bao Tian

Summary: This study presents a genomic and epidemiological analysis of Clostridioides difficile in a large teaching hospital, revealing a high detection rate, diverse genome characteristics, high antibiotic resistance, and potential nosocomial transmission risk. The findings provide new insights into surveillance and prevention of C. difficile-related diseases in China.

MICROBIOLOGY SPECTRUM (2022)

Article Infectious Diseases

Determining the in vitro susceptibility of tebipenem, an oral carbapenem, against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolated from bloodstream infections

Ama Ranasinghe, Andrew Henderson, Kyra Cottrell, Cindy S. E. Tan, Delaney Burnard, Hideo Kato, David L. Paterson, Patrick N. A. Harris

Summary: Tebipenem's in vitro activity is not affected by the production of ESBL and AmpC enzymes, and it retains its activity against strains resistant to ciprofloxacin and trimethoprim/sulfamethoxazole.

JAC-ANTIMICROBIAL RESISTANCE (2022)

暂无数据